TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | -4 | -3 | 26 | -6 | -18 | -37 | -7 |
| P | %wins | 50 | 25 | 50 | 50 | 0 | 50 | 38 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/4/16 15:31 | 8/2/16 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Van Deventer Sander | P7 | DT | P.d | 0 | 0.00 | 1 | 1,545 | 33 | 6,200 | I | -17 | -18 | 69 | 0 | -9 | -17 | -22 | -5 | 0 | -6 | -1 | -17 | -12 | ||
7/1/16 17:07 | 6/29/16 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Van Deventer Sander | P7 | DT | P.d | 0 | 0.00 | 3 | 1,323 | 40 | 4,655 | I | -23 | -11 | 151 | -9 | 7 | -17 | 9 | 14 | -8 | -3 | -18 | -30 | -25 | ||
3/16/16 16:37 | 3/14/16 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Van Deventer Sander | P7 | DT | P.d | 0 | 0.00 | 1 | 882 | 36 | 3,332 | I | -50 | -40 | -11 | 136 | 80 | 28 | 0 | 11 | -9 | -6 | 86 | 11 | -10 | -75 | |
2/12/14 18:13 | 2/12/14 | ARGS | Argos Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Van Deventer Sander | P7 | DT | P.d | 291 | 8.00 | 8 | 36 | 2 | 2,450 | I | 0 | 3 | 37 | 12 | -25 | 2 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |